India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets of many of the poorest is expected to be approved in India within six months.
Genentech’s Next Move
Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to come by combining drugs even before they are approved.
GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.
BIOTECH RALLIES The promise of new cancer therapies coming out of last week’s American Society of Clinical Oncology meeting in Chicago has helped restore vigor to the biopharmaceutical industry. It has also gotten a boost from a spate of new product approvals and generally upbeat earnings reports this year.